Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Pharvaris BV
PHVSCurrent price
14.00 USD
+0.19 USD (+1.40%)
Last closed
13.21 USD
Company
pharvaris.com
ISIN
NL00150005Y4
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
762 903 424 USD
Yield for 12 month
-32.92 %
1Y
3Y
5Y
10Y
15Y
PHVS
Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks which is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients which is under Phase 1 clinical trial. The company operates in the Netherlands, Switzerland, and the United States. Pharvaris N.V. was incorporated in 2015 and is based in Leiden, the Netherlands. Address: Emmy Noetherweg 2, Leiden, Netherlands, 2333 BK
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
35.73 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
-286 893 USD
Current Quarter
–
Last Quarter
–
Key Figures PHVS
1 year
3 years
5 years
10 years
EBITDA
-145 593 408 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-26.39 %
PEG Ratio
–
Return On Equity TTM
-41.18 %
Wall Street Target Price
35.73 USD
Revenue TTM
–
Book Value
4.92 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-2.80 USD
Diluted Eps TTM
-2.80 USD
Most Recent Quarter
I 2025
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics PHVS
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History PHVS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Stock Valuation PHVS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-1.38
Price Book MRQ
2.52
Financials PHVS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PHVS
For 52 weeks
11.51 USD
25.50 USD
50 Day MA
15.46 USD
Shares Short Prior Month
577 670
200 Day MA
18.27 USD
Short Ratio
14.19
Shares Short
590 657
Short Percent
1.42 %
BeatStart